Effect of Suvarnaprashana and Mahapaishachik Ghrita in the management of Autism in children.

An open labelled double arm randomised clinical controlled trial on Suvarnaprashana and Mahapaishachik Ghrita in the management of Autism Spectrum Disorder (ASD) in children. - ASD

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050235

Enrollment

Registered

2023-03-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a. Children aged between 2-6 years of age with clinical features of Autism Spectrum Disorder. b. Children already diagnosed with ASD and verified with INCLEN parameter. c. Parents willing to give informed written consent to participate in the study.

Exclusion criteria

Exclusion criteria: a. AGE 6 years. b. Children not fulfilling the screening criteria for diagnosis of ASD. c. Children of severe psychotic illness like conduct disorders. d. Children on psychiatric treatment. e. Children with chronic ailments like tuberculosis, malignancy etc.

Design outcomes

Primary

Measure	Time frame
IMPROVEMENT IN CLINICAL FEATURES OF ASD.Timepoint: At baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks.	—

Secondary

Measure	Time frame
INCREASE THE ATTENTION AND SOCIAL INTERACTION OF CHILDREN OF NEURODEVELOPMENTAL BEHAVIORAL DISORDERS BY SUVARNAPRASHANA AND MAHAPAISHACHIK GHRITA.Timepoint: In baseline, 12 weeks.	—

Countries

India

Contacts

Public ContactDR LAXMI

State Ayurvedic College and Hospital, Lucknow

lakshmiomsingh@gmail.com9792446688

Outcome results